http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010120121-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b9abfe8578fdcc57b6b1703951cb5c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91a95a55304bd565fd27abcdac683866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2010d8dc05b6f92b64686f59c42a94c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1769c818d0a84ddff15c89d075c71283
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fed7fd3c5c9b03030bc24980ae3d6ee4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5c98a95975fc3e4cdaf6840305c9ec2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d91b3c36db67250b912bfa241417f434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12180abcd6ec6360103a0e0808d34601
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44f04d319aaa6e66f240244bc905f452
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B30-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B30-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B35-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16C20-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1089
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06Q50-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B35-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B15-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B30-00
filingDate 2010-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5845da7bc7145ee45da471b1fdbce66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a68f5181ff53c0aab23d97e74dca8a7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33d2359c2a4b66e5d3077a21011f6aa9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4f012140bd9454057dcc8d77938ed3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_335eb24b87318c5e9c8693583af917d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e70d56677c3ea5c44fe31894d3d9fe5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f4d49421ed076c2214e7e1213f47430
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a994d7f9cd3307d508f0738da6c5508
publicationDate 2010-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2010120121-A2
titleOfInvention Target-specific non-antibody protein and method for preparing the same
abstract The present invention relates to a method for preparing a target-specific non-antibody protein, and more particularly, relates to a method for preparing a target-specific non-antibody protein comprising the steps of: sorting non-antibody proteins having a structural complementarity with the target site of a target protein in a non-antibody protein library; calculating binding energy of the sorted non-antibody protein and the target protein; sorting a non-antibody protein having stable binding energy among the sorted non-antibody proteins; selecting an amino acid residue having high binding energy among amino acid residues in which the target protein and the selected non-antibody protein are directly contacted; and substituting the selected amino acid residue with the amino acid residue having low binding energy. In addition, the present invention relates to a target-specific non-antibody which specifically binds with EGFR (Epidermal Growth Factor Receptor) domain 2, prepared by the method and a composition for treating cancers containing the same.
priorityDate 2009-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20080099278-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406433
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3000322

Total number of triples: 51.